[Federal Register Volume 77, Number 162 (Tuesday, August 21, 2012)]
[Notices]
[Page 50462]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-20547]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-64-2012]


Foreign-Trade Zone 59--Lincoln, NE, Notification of Proposed 
Production Activity; Novartis Consumer Health, Inc. (Pharmaceutical 
Products and Related Preparations Production), Lincoln, NE

    Novartis Consumer Health, Inc. (Novartis) submitted a notification 
of proposed production activity for the company's facilities located 
within Sites 3 and 4 of FTZ 59, in Lincoln, Nebraska. The facilities 
are used for the production of dosage-form and bulk-quantity mixed 
medicines, including those containing penicillin, alkaloids, 
analgesics, antibiotics, antihistamine/decongestants, cold remedies, 
anti-infectives, dermatological and anesthetic agents, digestive 
treatments, insulin, vitamins, and hormones; vitamins and provitamins; 
food preparations, including those containing fiber and various 
digestive products, lozenges, nicotine gum, and cold symptom products; 
preparations for skincare; pharmaceutical reference standards; and 
medicines for veterinary use.
    Production under FTZ procedures could exempt Novartis from customs 
duty payments on the foreign-status components used in export 
production. On its domestic sales, Novartis would be able to choose the 
duty rates during customs entry procedures that apply to the finished 
products (mostly duty-free, but some would be up to 6.4 percent for 
certain food preparations) for the foreign-status inputs noted below. 
Customs duties also could possibly be deferred or reduced on foreign 
status production equipment.
    Components and materials sourced from abroad include: Menthol; 
ibuprofen; sodium salicylate (USP); aspirin; terbinafine; 
diphenhydramine citrate (USP); diclofenac sodium; acetaminophen; 
rivastigmine hydrogen tartrate; tolnaftate (USP/EP); lansoprazole; 
loratadine; pyrilamine maleate (USP); dextromethorphan HBR (USP); 
clemastine fumarate; clomipramine hydrochloride; acesulfame K; 
benzalkonium chloride; microcrystalline cellulose; inulin; aloe vera 
gel; carrageenan (viscarin GP109F); wheat dextrin; insulin; benzyl 
alcohol NF; camphor USP; synthetic; anhydrous citric acid USP/EP find 
grain; butylparaben NF; methylparaben NF; diphenhydramine citrate USP; 
aspartame NF; aspartame; coated acetaminophen crystals; xylometazoline 
HCL; heterocyclic compounds; dextromethorphan hydrobromide USP; 
crospovideone NF; polyplasdone xl-10; clomicalm A.S.; isradipine (USP); 
desiccant; croscarmellose sodium NF; microcellulose; bulk penicillin 
mixed medicines; bulk mixed drugs; including penicillins; antibiotics; 
hormones; and alkaloids; caffeine; dextrins and modified starches; 
gums; guar gum; oleoresins; balsam gum; ginseng; vegetable extracts and 
similar thickeners; iron oxides and hydroxides; disodium carbonate; 
carbonates; flavoring compounds; aniline derivative compounds; amino-
alcohol-phenols; amino-acid-phenols; other nitrile function compounds; 
other antihistamine chemicals; other vegetable alkaloids and 
derivatives; articles of plastic, including bands, bags and fiber drum 
liners, bottles, plugs, caps, drums, tubes, packaging materials, 
droppers, stoppers, dispensing tubes, plug dip tubes, dosage cups and 
syringes; stopper dip tube assemblies; aluminum collapsible tubes; 
aluminum containers; artificial flavors; pine needle oil; benorilate; 
and sodium cyclamate (duty rates range from duty free to 6.5%).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary at the address 
below. The closing period for their receipt is October 1, 2012.
    A copy of the notification will be available for public inspection 
at the Office of the Executive Secretary; Foreign-Trade Zones Board; 
Room 21013; U.S. Department of Commerce; 1401 Constitution Avenue NW., 
Washington, DC 20230-0002; and in the ``Reading Room'' section of the 
Board's Web site; which is accessible via www.trade.gov/ftz.
    For further information; contact Diane Finver at 
[email protected] or (202) 482-1367.

    Dated: August 14, 2012.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2012-20547 Filed 8-20-12; 8:45 am]
BILLING CODE P